Table I.
Associations between MALAT1 expression and the clinical characteristics of patients with non-small cell lung cancer.
| MALAT1 | ||||
|---|---|---|---|---|
| Term | Low-expression | High-expression | χ2 | P-value |
| Sex | ||||
| Male | 69 | 40 | 5.467 | 0.019 |
| Female | 3 | 8 | ||
| Age, year | ||||
| ≤50 | 25 | 24 | 0.025 | 0.838 |
| >50 | 37 | 34 | ||
| Maximum diameter, cm | ||||
| ≤5 | 38 | 33 | 0.629 | 0.504 |
| >5 | 24 | 25 | ||
| Tumor number | ||||
| Single | 21 | 19 | 0.012 | 0.905 |
| Multiple | 43 | 37 | ||
| TNM stage | ||||
| I–II | 32 | 20 | 5.172 | 0.016 |
| III–IV | 20 | 48 | ||
| Vessel invasion | ||||
| No | 35 | 45 | 6.483 | 0.032 |
| Yes | 8 | 32 | ||
| Pathological differentiation | ||||
| High-medium | 23 | 65 | 12.383 | 0.013 |
| Low | 0 | 32 | ||
| Recurrence | ||||
| No | 30 | 15 | 9.542 | 0.006 |
| Yes | 24 | 51 | ||
MALAT1, metastasis-associated lung adenocarcinoma transcript 1; TNM, tumor, node, metastasis. P<0.05 was considered to indicate a statistically significant difference.